StemoniX
Pre-plated, human iPSC-derived microOrgans for toxicology and drug discovery research
1 employees · est. 2014 · Maple Grove, United States
StemoniX is the older company (2015 vs 2014); Metrion Biosciences is the larger of the two.
Side-by-Side Comparison
| Metric | Metrion Biosciences | StemoniX |
|---|---|---|
| Founded | ||
| Founded | 2015 | 2014 older |
| Headquarters | ||
| Headquarters | Cambridge, United Kingdom | Maple Grove, United States |
| Employees | ||
| Employees | 42 larger | 1 |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series C | Convertible Note |
| Total Funding | ||
| Total Funding | $7.84M | $33.21M |
| Funding Rounds | ||
| Funding Rounds | 6 | 11 |
| Services | ||
| Services | Ion Channel Screening, Cardiac Safety Screening, Neuroscience Services, GLP hERG Testing, Integrated Drug Discovery | Not tracked yet |
| Target Customers | ||
| Target Customers | pharmaceutical companies, biotechnology firms, academic research institutions, drug discovery organizations | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Ion Channel Screening, Drug Discovery Services, Preclinical CRO, High-Throughput Assays, Translational Cardiac Safety, Neuroscience Assays, DRG Neurons, Pharmaceutical R&D, Biotech Operations, Automated Patch Clamp, HERG Testing, Ion Channel Assays, Manual Patch Clamp, Pain Assays, GLP HERG Screening | Stem Cell Technologies, Drug Discovery, Personalized Medicine, IPS Cells, Cardiomyocytes, Neurons, Astrocytes, High Throughput Screening, In Vitro Assay Development, Disease Modeling, Hazard Identification, Cell-based Assays, Toxicology Research, Regenerative Medicine |
| Website | ||
| Website | metrionbiosciences.com | stemonix.com |
About Metrion Biosciences
Metrion Biosciences positions itself as a specialist preclinical CRO, delivering sophisticated drug discovery services with a strong focus on ion channel screening and high-throughput assays. Their comprehensive offerings include translational cardiac safety and specialized neuroscience assays using...
About StemoniX
StemoniX is a biotechnology startup based in the United States, founded in 2014, focusing on accelerating the discovery of new medicines through the development and scalable manufacture of human induced pluripotent stem (iPS) cell-derived cardiac and neural platforms for drug discovery and developme...
We will tell you when either one moves
BounceWatch watches Metrion Biosciences and StemoniX for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Metrion Biosciences and StemoniX — by email.
Frequently Asked Questions
Compare Metrion Biosciences with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Metrion Biosciences on 29 Mar 2026, and StemoniX on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.